Alector, Inc.
NASDAQ:ALECBiotechnology
Healthcare
$2.57 +5.13%
+$0.08 today
- Market cap
- $382.61M
- Beta
- 0.59
- P/E (TTM)
- -1.4
- EPS (TTM)
- -$1.13
52W Low $1.09High $3.40
Volume 2.13M
Average 0.65M
Income Statement
Follow revenue through to earnings.
Revenue
$21.05M
FY 2025 · Annual
-79.1% YoYOperating Income
-$145.81M
FY 2025 · Annual
Net Income
-$142.93M
FY 2025 · Annual
Income Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 207.09M | 133.62M | 97.06M | 100.56M | 21.05M |
| Cost of Revenue | 189.41M | 0 | 8.85M | 185.94M | 9.66M |
| Gross Profit | 17.68M | 133.62M | 88.21M | (85.38M) | 11.38M |
| Gross Margin | 8.5% | 100.0% | 90.9% | -84.9% | 54.1% |
| Research & Development | 189.41M | 210.42M | 192.12M | 209.24M | 123.07M |
| Selling, General & Admin | 55.04M | 61.03M | 56.69M | 57.41M | 53.99M |
| Operating Expenses | 55.04M | 271.45M | 239.95M | 59.62M | 157.19M |
| Depreciation & Amortization | 8.32M | 8.47M | 8.85M | 8.84M | 9.66M |
| EBITDA | (28.01M) | (121.58M) | (116.33M) | (110.08M) | (133.1M) |
| EBITDA Margin | -13.5% | -91.0% | -119.9% | -109.5% | -632.5% |
| Operating Income | (37.36M) | (137.83M) | (151.74M) | (145M) | (145.81M) |
| Operating Margin | -18.0% | -103.2% | -156.3% | -144.2% | -692.8% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 1.03M | 7.78M | 26.56M | 26.08M | 3.05M |
| Income Before Tax | (36.33M) | (130.06M) | (125.18M) | (118.92M) | (142.76M) |
| Pre-Tax Margin | -17.5% | -97.3% | -129.0% | -118.3% | -678.4% |
| Income Tax Expense | 0 | 3.25M | 5.21M | 128K | 168K |
| Net Income | (36.33M) | (133.31M) | (130.39M) | (119.05M) | (142.93M) |
| Net Margin | -17.5% | -99.8% | -134.3% | -118.4% | -679.2% |
| EPS (Basic) | (0.45) | (1.62) | (1.56) | (1.23) | (1.39) |
| EPS (Diluted) | (0.45) | (1.62) | (1.56) | (1.23) | (1.39) |
| 80.42M | 82.47M | 83.73M | 96.59M | 103M | |
| 80.42M | 82.47M | 83.73M | 96.59M | 103M |
ALEC Earnings Waterfall · TTM
NASDAQ:ALEC · Revenue to Net Income
Key Ratios
EPS$-1.19
Gross Margin-37.5%
Net Margin-1060.2%
P/E Ratio-1.8
P/S Ratio91.0
Analysis
$18.4M of revenue converted into -$125.4M of net income for the selected period. Gross margin is -37.5% and net margin is -1060.2%, showing how much revenue survives after costs and taxes. EPS is $-1.19, tying the income statement back to per-share earnings.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 5, 2026 | |
| 10-Q | Quarterly report | Nov 5, 2026 | |
| SC 13G | SC 13G filing | Oct 26, 2026 | |
| SC 13G | SC 13G filing | Oct 23, 2026 | |
| 8-K | Current report | Oct 16, 2026 |
How much revenue does ALEC generate?
Alector, Inc. (ALEC) reported $21.05M of revenue in fiscal 2025.
Is ALEC profitable?
Alector, Inc. (ALEC) reported -$142.93M of net income, with a net margin of -679.2%.
Continue the stock analysis
Jump to another research area for this company.